miscsubjectsAI governance
Evidence review

TB-500 for Neuropathy: Evidence-Graded Review of Repair Pathways

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tb-500-neuropathy`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tb-500-neuropathy

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-neuropathy/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-neuropathy/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-neuropathy/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-neuropathy/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: TB-500 (thymosin beta-4) is studied for repair-cell migration and actin regulation — cells that need to reach an injury and rebuild structure. That is regeneration: move repair machinery to the damage.

Why TB-500 might help you

  1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
  2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
  3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • TB-500 → inflammation clearance / repair-cell migration

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 1
  • Total sources in chain: 5

Quantified confidence (this ledger): 0.41 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Thymosin β4 Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice (source s1)

Mouse study showing Tβ4 effects on diabetic neuropathy conduction and vascular function.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Researchers Report that Long-Term Administration of Thymosin B4 Prevents Progression of Peripheral Neuropathy (source s2)

Press release on extended Tβ4 treatment in diabetic neuropathy mouse model.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair (source s3)

2026 scoping review confirming lack of neuropathy-specific human trials.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Healing Compounds - BPC-157, TB-500 — Reddit, r/steroids (source s5)

User anecdote on stacked peptides including TB-500 for neuropathy-related symptoms.

Safety and limits

  1. Phase 1 safety studies in healthy volunteers showed thymosin beta-4 was well tolerated with no dose-limiting toxicities.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Neuropathy (general) · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 5 sources · swipe →chain 47aefa479d03 · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
human
Phase 1 safety studies in healthy volunteers showed thymosin beta-4 was well tolerated with no dose-limiting toxicities.
sources: s4
preclinical
Long-term thymosin beta-4 administration in diabetic mice prevented progression of peripheral neuropathy and partially restored sciatic nerve function.
sources: s2
humanlow confidence
No randomized controlled human trials of TB-500 or thymosin beta-4 for neuropathy exist as of 2026.
sources: s3
preclinicallow confidence
In a 2012 mouse model of diabetic peripheral neuropathy, thymosin beta-4 treatment improved sciatic nerve conduction velocity and neurovascular function compared to untreated controls.
sources: s1
anecdotallow confidence
Reddit users report subjective improvements in neuropathy symptoms when using TB-500 in stacks, often alongside BPC-157, but results are uncontrolled anecdotes.
sources: s5
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:34
TB-500 for Neuropathy: Evidence-Graded Review of Repair Pathways · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: TB 500 for Neuropathy
Slug: tb-500-neuropathy
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"tb-500","name":"TB-500"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative
it output
{
  "slug": "tb-500-neuropathy",
  "title": "TB-500 for Neuropathy: Evidence-Graded Review of Repair Pathways",
  "body": "## What's breaking down\n\nNeuropathy involves progressive nerve fiber damage, loss of myelin, reduced blood supply to nerves, and persistent low-grade inflammation. These layers slow or block the body's natural repair signals. Repair cells often fail to reach damaged axons. Actin and cytoskeleton structures inside cells become disorganized. Blood vessels feeding the nerves weaken or disappear. Inflammation lingers instead of clearing. Over time, conduction velocity drops and sensation or motor function declines.\n\nIf your neuropathy stems from diabetes, injury, or idiopathic causes, the core issue is that degeneration outruns regeneration. Standard approaches may suppress symptoms or reduce mechanical stress but do not directly target the migration of repair cells or the reorganization of the cellular scaffolding needed for nerve regrowth.\n\n## Why TB-500 might help you\n\n1. What keeps failing: Repair cells do not reach the injury site. Inflammation stalls instead of resolving. Actin and cytoskeleton inside cells lose organization, blocking new axon growth and blood vessel formation.\n\n2. What TB-500 is studied to do: TB-500 is a fragment of thymosin beta-4. Research examines how it sequesters actin, promotes cell migration to damage zones, supports an
9539c9260fae7e55
Machine verification: /api/articles/tb-500-neuropathy/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Phase 1 safety studies in healthy volunteers showed thymosin beta-4 was well tolerated with no dose-limiting toxicities."?
ask tb-500-neuropathy claim c4 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Long-term thymosin beta-4 administration in diabetic mice prevented progression of peripheral neuropathy and partially restored sciatic nerv…"?
ask tb-500-neuropathy claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "No randomized controlled human trials of TB-500 or thymosin beta-4 for neuropathy exist as of 2026."?
ask tb-500-neuropathy claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "In a 2012 mouse model of diabetic peripheral neuropathy, thymosin beta-4 treatment improved sciatic nerve conduction velocity and neurovascu…"?
ask tb-500-neuropathy claim c1 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users report subjective improvements in neuropathy symptoms when using TB-500 in stacks, often alongside BPC-157, but results are unc…"?
ask tb-500-neuropathy claim c5 · paste includes §SELF
Summarize this youtube report and how it should weigh: "Summary of early human safety data for thymosin beta-4."
ask tb-500-neuropathy source s4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdote on stacked peptides including TB-500 for neuropathy-related symptoms."
ask tb-500-neuropathy source s5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about TB-500 for Neuropathy: Evidence-Graded Review of Repair Pathways — and what would you need me to tell you first?
ask tb-500-neuropathy condition gaps · paste includes §SELF
tb-500-neuropathy · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 20575 tokens · $0 · 2 models
chain head 3c4e346fb04e5c61
write grok/grok-4.3 · 2026-06-29 23:34 · 20575 tok · ff56eb761432
voxel_divide owner · 2026-07-17 02:42 · tokens unrecorded · 3c4e346fb04e
verify chain →
Live ledger · 31 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-29 05:10
JCI_CLASSIFY jci · HTTP 200 · 2026-07-29 05:10
JCI_TRAFFIC jci · HTTP 200 · 2026-07-29 05:10
JCI_TRAFFIC jci · HTTP 200 · 2026-07-29 05:02
JCI_TRAFFIC jci · HTTP 200 · 2026-07-28 14:36
JCI_TRAFFIC jci · HTTP 200 · 2026-07-28 13:07
view full ledger & cards →
REST + ledger
read GET /api/articles/tb-500-neuropathy · GET /api/articles/tb-500-neuropathy?format=post (the editable body)
create/replace POST /api/articles/tb-500-neuropathy · PUT /api/articles/tb-500-neuropathy (replace, keeps revision) · PATCH /api/articles/tb-500-neuropathy (merge)
delete DELETE /api/articles/tb-500-neuropathy
writes need header x-terminal-key
LLM bundle GET /api/articles/tb-500-neuropathy/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim tb-500-neuropathy|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →